Falck H M, Maury C P, Teppo A M, Wegelius O
Br Med J (Clin Res Ed). 1983 Apr 30;286(6375):1391-3. doi: 10.1136/bmj.286.6375.1391.
The importance of serum amyloid A protein in the progression of renal failure was studied over three years in 28 patients with secondary (amyloid A type) amyloidosis predominantly due to rheumatoid arthritis. Creatinine clearance, the amount of protein in the urine, and serum amyloid A and C-reactive protein concentrations were determined regularly. Linear regression analysis showed a close correlation between the change in creatinine clearance each year and both serum amyloid A concentrations (20 patients: r= -0.83, p less than 0.001) and C-reactive protein concentrations (28 patients: r= -0.80, p less than 0.001). The correlation between serum amyloid A and C-reactive protein concentrations was also significant (317 parallel measurements: r=0.81, p less than 0.001). These findings suggest that monitoring serum amyloid A or C-reactive protein concentrations is valuable in assessing the prognosis in secondary amyloidosis and that therapeutic measures that lower serum amyloid A concentrations may reduce the formation of amyloid.
在三年时间里,对28例主要因类风湿关节炎导致的继发性(淀粉样蛋白A类型)淀粉样变性患者,研究了血清淀粉样蛋白A在肾衰竭进展中的重要性。定期测定肌酐清除率、尿蛋白量以及血清淀粉样蛋白A和C反应蛋白浓度。线性回归分析显示,每年肌酐清除率的变化与血清淀粉样蛋白A浓度(20例患者:r = -0.83,p < 0.001)和C反应蛋白浓度(28例患者:r = -0.80,p < 0.001)均密切相关。血清淀粉样蛋白A与C反应蛋白浓度之间的相关性也很显著(317次平行测量:r = 0.81,p < 0.001)。这些发现表明,监测血清淀粉样蛋白A或C反应蛋白浓度对于评估继发性淀粉样变性的预后很有价值,并且降低血清淀粉样蛋白A浓度的治疗措施可能会减少淀粉样蛋白的形成。